NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,846,492 | -68.9% | 1,084,625 | -58.9% | 0.00% | -66.7% |
| Q2 2023 | $67,104,529 | -79.4% | 2,639,832 | -70.7% | 0.01% | -60.0% |
| Q1 2023 | $325,414,852 | +58.4% | 9,001,794 | +73.6% | 0.02% | -25.0% |
| Q4 2022 | $205,399,379 | +1.2% | 5,186,853 | +19.1% | 0.02% | -4.8% |
| Q3 2022 | $202,908,000 | +312.5% | 4,354,248 | +288.0% | 0.02% | +320.0% |
| Q2 2022 | $49,189,000 | -55.9% | 1,122,262 | -27.3% | 0.01% | -44.4% |
| Q1 2022 | $111,608,000 | +51.3% | 1,543,040 | +69.6% | 0.01% | +80.0% |
| Q4 2021 | $73,753,000 | -51.8% | 909,742 | -30.9% | 0.01% | -58.3% |
| Q3 2021 | $153,126,000 | -59.3% | 1,315,749 | -42.0% | 0.01% | -58.6% |
| Q2 2021 | $376,153,000 | +35.7% | 2,268,845 | +14.2% | 0.03% | +20.8% |
| Q1 2021 | $277,255,000 | +11.3% | 1,987,489 | +38.1% | 0.02% | +9.1% |
| Q4 2020 | $249,119,000 | +5.6% | 1,439,166 | -15.0% | 0.02% | -8.3% |
| Q3 2020 | $235,971,000 | -10.6% | 1,693,978 | -23.3% | 0.02% | -17.2% |
| Q2 2020 | $263,848,000 | +221.2% | 2,208,482 | +168.8% | 0.03% | +163.6% |
| Q1 2020 | $82,150,000 | +91.4% | 821,660 | +125.1% | 0.01% | +120.0% |
| Q4 2019 | $42,914,000 | +476722.2% | 365,100 | +365000.0% | 0.01% | – |
| Q3 2019 | $9,000 | +50.0% | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -50.0% | 100 | -48.5% | 0.00% | – |
| Q3 2018 | $12,000 | -100.0% | 194 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $46,553,000 | +37.0% | 583,000 | +48.7% | 0.01% | +25.0% |
| Q1 2018 | $33,975,000 | +30.9% | 392,000 | +37.3% | 0.00% | +33.3% |
| Q3 2017 | $25,946,000 | -71.6% | 285,502 | -76.7% | 0.00% | -72.7% |
| Q2 2017 | $91,326,000 | -55.8% | 1,227,009 | -44.3% | 0.01% | -57.7% |
| Q1 2017 | $206,579,000 | +5.4% | 2,204,685 | -18.2% | 0.03% | 0.0% |
| Q4 2016 | $195,930,000 | -54.3% | 2,696,526 | -34.3% | 0.03% | -54.4% |
| Q3 2016 | $428,771,000 | +38.8% | 4,107,397 | -1.9% | 0.06% | +35.7% |
| Q2 2016 | $308,920,000 | +29.9% | 4,188,187 | -0.9% | 0.04% | +27.3% |
| Q1 2016 | $237,824,000 | -1.9% | 4,227,232 | +17.7% | 0.03% | 0.0% |
| Q4 2015 | $242,378,000 | +82.0% | 3,590,260 | +25.1% | 0.03% | +73.7% |
| Q3 2015 | $133,179,000 | +47.6% | 2,870,850 | +71.0% | 0.02% | +58.3% |
| Q2 2015 | $90,250,000 | +112.5% | 1,679,062 | +89.5% | 0.01% | +140.0% |
| Q1 2015 | $42,476,000 | +22.9% | 886,200 | -0.8% | 0.01% | +25.0% |
| Q4 2014 | $34,552,000 | – | 893,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |